Skip to main content

Mustgrow Biologics Corp(MGRO-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.550
Day High0.550
Open:0.550
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Mustgrow Biologics Corp

Select a category then submit the form to load news
MustGrow's Canola Field Trials Demonstrate Clubroot Disease Suppression; Improved Canola Yield with Healthier Root Systems
MustGrow Closes $2.0 Million Non-Brokered LIFE Offering
MustGrow Announces Non-Brokered LIFE Offering of up to $2 Million
MustGrow: CEO Letter to Shareholders 2025
MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante(TM)
MustGrow Announces Record Q3-2025 Results
2025 Cantech Investment Conference Announces Presenting Companies and Exclusive Networking Events
MustGrow Announces Grant of RSUs and DSUs
MustGrow Secures $2 Million Line of Credit with CIBC; Guaranteed by EDC
MustGrow Closes Non-Brokered LIFE Offering of Approximately $2.1 Million, Repricing of Warrants, and Shares for Debt Settlement
MustGrow Announces Record Q2-2025 Results: $2.8 Million Revenue and 20.9% Gross Profit Margin for the Quarter
MustGrow annonce un placement sans intermédiaire sous le régime de la dispense pour financement de l'émetteur coté d'un montant maximal de 3 millions de dollars, une proposition de révision du prix des bons de souscription, et une offre d'actions aux porteurs de débentures aux fins du règlement de dettes
MustGrow Announces Non-Brokered LIFE Offering of up to $3 Million, Proposed Repricing of Warrants, and Shares for Debt Settlement Offer to Debentureholders
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
MustGrow and Phospholutions Sign Canadian Distribution Agreement for Phosphorous Efficiency Product - RhizoSorb(R)
MustGrow Announces Record Q1-2025 Results: $3.8 Million Revenue, 14.3% Gross Profit Margin, $4.4 Million in Cash and Inventory
MustGrow Adds New Biostimulants and Inoculants to Canadian Product Portfolio
MustGrow Signs Exclusive Distribution Agreement with Adjuvants Plus Inc. for Biological Product Line
MustGrow Announces Closing of Private Placement of Units for $2,585,000
MustGrow Biologics Completes Acquisition of NexusBioAg
MustGrow Biologics Announces Proposed Private Placement of Units for Approximately $2 Million
MustGrow Biologics Signs Non-Binding Term-Sheet for Acquisition of NexusBioAg
MustGrow Provides 2024 Pipeline Update
MustGrow Receiving Funding from Agriculture and Agri-Food Canada for Human and Animal Health Applications
MustGrow Receives Florida Registration for TerraSante(TM) Biofertility Product
MustGrow Announces Grant of RSUs and DSUs
MustGrow Receives Arizona Registration for TerraSante(TM) Biofertility Product
MustGrow Receives Idaho Registration and Organic Approval for TerraSante(TM) Biofertility Product
MustGrow Accelerates California Sales and Marketing Efforts for TerraSante(TM) Biofertility Product
MustGrow Joins Industry Consortium "Global Alliance Against TR4" to defeat Banana Fungal Disease Fusarium wilt TR4

Profile

MustGrow Biologics Corp is a fully integrated provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.